Literature DB >> 32557089

Paralytic ileus after planned abdominal surgery in a patient on treatment with erenumab.

Ilaria Frattale1, Raffaele Ornello2, Francesca Pistoia2, Valeria Caponnetto2, Enrico Colangeli2, Simona Sacco2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32557089     DOI： 10.1007/s11739-020-02407-y

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  3 in total

Review 1.  European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update.

Authors:  Simona Sacco; Faisal Mohammad Amin; Messoud Ashina; Lars Bendtsen; Christina I Deligianni; Raquel Gil-Gouveia; Zaza Katsarava; Antoinette MaassenVanDenBrink; Paolo Martelletti; Dimos-Dimitrios Mitsikostas; Raffaele Ornello; Uwe Reuter; Margarita Sanchez-Del-Rio; Alexandra J Sinclair; Gisela Terwindt; Derya Uluduz; Jan Versijpt; Christian Lampl
Journal:  J Headache Pain       Date:  2022-06-11       Impact factor: 8.588

Review 2.  Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes.

Authors:  Eleonora De Matteis; Simona Sacco; Raffaele Ornello
Journal:  Ther Clin Risk Manag       Date:  2022-04-05       Impact factor: 2.423

3.  Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study.

Authors:  Hannah Schenk; Dagny Holle; Michael Nsaka; Christoph Kleinschnitz; Martin Glas; Armin Scheffler
Journal:  J Headache Pain       Date:  2022-05-11       Impact factor: 7.277
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.